×
About 2,727 results

ALLMedicine Ovarian Insufficiency Center

Research & Reviews  1,301 results

The protective effects of pretreatment with resveratrol in cyclophosphamide-induced rat...
https://doi.org/10.1016/j.reprotox.2020.05.005
Reproductive Toxicology (Elmsford, N.Y.); Nie Z, Zhang L et. al.

May 24th, 2020 - Cyclophosphamide (Cy), a chemotherapeutic agent, is widely used to treat tumoursand is also associated with premature ovarian insufficiency. 4-Hydroperoxycyclophosphamide (4-HC), an active metabolite of Cy, was used for in vitro experiments. Granu...

Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention ...
https://doi.org/10.1016/j.ejca.2020.03.030
European Journal of Cancer (Oxford, England : 1990); Choi MC, Chung YS et. al.

May 22nd, 2020 - This study assessed the effects of gonadotropin-releasing hormone agonists (GnRHa) on the prevention of chemotherapy-induced ovarian insufficiency among young patients with malignant ovarian germ cell tumour (MOGCT) receiving chemotherapy. This mu...

The role of oxidative stress on subclinical atherosclerosis in premature ovarian insuff...
https://doi.org/10.1080/09513590.2020.1766439
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology; Bozkaya VÖ, Yumusak OH et. al.

May 19th, 2020 - Objective: We aimed to investigate the relationship between oxidative stress (OS) and subclinical atherosclerosis in patients with premature ovarian insufficiency (POI), by analyzing the dynamic thiol/disulfide homeostasis (TDH) parameters as an O...

Diminished Ovarian Reserve Chemotherapy-Induced Mouse Model: A Tool for the Preclinical...
https://doi.org/10.1007/s43032-020-00191-w
Reproductive Sciences (Thousand Oaks, Calif.); Buigues A, Marchante M et. al.

May 18th, 2020 - Diminished ovarian reserve (DOR) and primary ovarian insufficiency (POI) are primary factors leading to infertility. However, there is a lack of appropriate animal models of DOR usable for assessing new therapeutic strategies. In this study, we ai...

GGPS1 Mutations Cause Muscular Dystrophy/Hearing Loss/Ovarian Insufficiency Syndrome.
https://doi.org/10.1002/ana.25772
Annals of Neurology; Foley AR, Zou Y et. al.

May 13th, 2020 - A hitherto undescribed phenotype of early onset muscular dystrophy associated with sensorineural hearing loss and primary ovarian insufficiency was initially identified in two siblings and in subsequent patients with a similar constellation of fin...

see more →

Guidelines  7 results

Committee Opinion No. 698: Hormone Therapy in Primary Ovarian Insufficiency.
https://doi.org/10.1097/AOG.0000000000002044
Obstetrics and Gynecology;

Apr 20th, 2017 - Primary ovarian insufficiency describes a spectrum of declining ovarian function and reduced fecundity due to a premature decrease in initial follicle number, an increase in follicle destruction, or poor follicular response to gonadotropins. The s...

Committee Opinion No. 698 Summary: Hormone Therapy in Primary Ovarian Insufficiency.
https://doi.org/10.1097/AOG.0000000000002040
Obstetrics and Gynecology;

Apr 20th, 2017 - Primary ovarian insufficiency describes a spectrum of declining ovarian function and reduced fecundity due to a premature decrease in initial follicle number, an increase in follicle destruction, or poor follicular response to gonadotropins. The s...

The British Menopause Society and Women's Health Concern recommendations on the managem...
https://doi.org/10.1177/2053369117699358
Post Reproductive Health; Hamoda H,

Apr 6th, 2017 - The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency.|2017|Hamoda H, ,|epidemiology,etiology,adverse effects,methods,etiology,complications,drug therapy,etiology,p...

ESHRE Guideline: management of women with premature ovarian insufficiency.
https://doi.org/10.1093/humrep/dew027
Human Reproduction (Oxford, England); , Webber L et. al.

Mar 24th, 2016 - What is the optimal management of women with premature ovarian insufficiency (POI) based on the best available evidence in the literature? The guideline development group (GDG) formulated 99 recommendations answering 31 key questions on the diagno...

ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific...
https://doi.org/10.1038/gim.2013.61
Genetics in Medicine : Official Journal of the American College of Medical Genetics; Monaghan KG, Lyon E et. al.

Jun 14th, 2013 - Molecular genetic testing of the FMR1 gene is commonly performed in clinical laboratories. Mutations in the FMR1 gene are associated with fragile X syndrome, fragile X tremor ataxia syndrome, and premature ovarian insufficiency. This document prov...

see more →

Clinicaltrials.gov  1,365 results

The protective effects of pretreatment with resveratrol in cyclophosphamide-induced rat...
https://doi.org/10.1016/j.reprotox.2020.05.005
Reproductive Toxicology (Elmsford, N.Y.); Nie Z, Zhang L et. al.

May 24th, 2020 - Cyclophosphamide (Cy), a chemotherapeutic agent, is widely used to treat tumoursand is also associated with premature ovarian insufficiency. 4-Hydroperoxycyclophosphamide (4-HC), an active metabolite of Cy, was used for in vitro experiments. Granu...

Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention ...
https://doi.org/10.1016/j.ejca.2020.03.030
European Journal of Cancer (Oxford, England : 1990); Choi MC, Chung YS et. al.

May 22nd, 2020 - This study assessed the effects of gonadotropin-releasing hormone agonists (GnRHa) on the prevention of chemotherapy-induced ovarian insufficiency among young patients with malignant ovarian germ cell tumour (MOGCT) receiving chemotherapy. This mu...

The role of oxidative stress on subclinical atherosclerosis in premature ovarian insuff...
https://doi.org/10.1080/09513590.2020.1766439
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology; Bozkaya VÖ, Yumusak OH et. al.

May 19th, 2020 - Objective: We aimed to investigate the relationship between oxidative stress (OS) and subclinical atherosclerosis in patients with premature ovarian insufficiency (POI), by analyzing the dynamic thiol/disulfide homeostasis (TDH) parameters as an O...

Diminished Ovarian Reserve Chemotherapy-Induced Mouse Model: A Tool for the Preclinical...
https://doi.org/10.1007/s43032-020-00191-w
Reproductive Sciences (Thousand Oaks, Calif.); Buigues A, Marchante M et. al.

May 18th, 2020 - Diminished ovarian reserve (DOR) and primary ovarian insufficiency (POI) are primary factors leading to infertility. However, there is a lack of appropriate animal models of DOR usable for assessing new therapeutic strategies. In this study, we ai...

GGPS1 Mutations Cause Muscular Dystrophy/Hearing Loss/Ovarian Insufficiency Syndrome.
https://doi.org/10.1002/ana.25772
Annals of Neurology; Foley AR, Zou Y et. al.

May 13th, 2020 - A hitherto undescribed phenotype of early onset muscular dystrophy associated with sensorineural hearing loss and primary ovarian insufficiency was initially identified in two siblings and in subsequent patients with a similar constellation of fin...

see more →

News  41 results

UK Guidelines Quiz – Menopause: Diagnosis and Management
https://www.medscape.com/viewarticle/919637

Oct 17th, 2019 - In the reviewed guideline: ‘Menopause: diagnosis and management’ the National Institute for Health and Care Excellence (NICE) aims to improve the consistency of support and information provided to women in menopause. It includes guidance for the d...

No increase in primary ovarian insufficiency with HPV vaccine
https://www.mdedge.com/obgyn/article/172987/vaccines/no-increase-primary-ovarian-insufficiency-hpv-vaccine
Bianca Nogrady

Aug 21st, 2018 - The human papillomavirus vaccine does not appear to be associated with an increased risk of ovarian insufficiency, according to researchers. Choreograph/Thinkstock Allison L.

VIDEO: Dr. Matteo Lambertini answers questions on temporary ovarian suppression
https://www.mdedge.com/obgyn/article/153819/breast-cancer/video-dr-matteo-lambertini-answers-questions-temporary-ovarian
Susan London

Dec 7th, 2017 - SAN ANTONIO – A meta-analysis of five trials among 873 premenopausal women with early breast cancer finds that temporarily suppressing ovarian function with a gonadotropin-releasing hormone analog during chemotherapy helps preserve fertility, redu.

Which Cancer Patients Should Have Ovary Cryopreservation?
https://www.medscape.com/viewarticle/830510

Aug 26th, 2014 - The first study to test the Edinburgh selection criteria for ovary tissue cryopreservation in pediatric cancer patients has shown that they are an accurate predictor. The criteria accurately identify the few girls and young women who will develop ...

ESHRE writes first premature ovarian insufficiency guidelines
https://www.mdedge.com/internalmedicine/article/86417/gynecology/eshre-writes-first-premature-ovarian-insufficiency
Mitchel L. Zoler

Aug 12th, 2014 - MUNICH – A working group of the European Society of Human Reproduction and Embryology drafted the first international guidelines for managing premature ovarian insufficiency. Once formally released, by late this year or soon after, the guidelines.

see more →

Patient Education  13 results see all →